Author: healthadmin
A study comparing psychedelic enthusiasts and the general public (those who have had psychedelic experiences) found that enthusiasts tended to report a much greater positive effect on their quality of life. Enthusiasts also showed higher levels of directness, extraversion, and agreeableness. This indicates that recruitment strategies focused on including enthusiasts in psychedelic research can shape the outcomes obtained in the research. The paper was published in. Psychotropic Drugs Journal. Psychedelic drugs are substances that can significantly alter perception, mood, thinking, and sense of self. These can change the way people experience colors, sounds, time, memories, emotions, and the meaning of…
Older people who cut back on fat in their diets and reduced their intake of animal protein showed signs of becoming biologically younger, according to new research from the University of Sydney. This research aged cellsfound that adults between the ages of 65 and 75 experienced a decrease in their estimated “biological age” after following a specific diet for just four weeks. Researchers say the findings suggest that changing your diet later in life can quickly improve markers associated with aging and overall health. The research was led by Dr Caitlin Andrews from the School of Life and Environmental Sciences…
With positive momentum building on plans for the second half of 2025, European Union legislators have taken an important step towards introducing a new regional framework focused on expanding supplies of critical medicines and resolving potential drug shortages. According to an announcement on May 12, the Council of the European Union and the European Parliament have reached a tentative agreement on this regulation, allowing the European Union to move forward with its proposed Critical Medicines Act (CMA). The framework, which still needs to be finalized and formally approved by the EU Council and Parliament, was introduced last March to avoid…
Virtual care and health navigation company Included Health has launched a new artificial intelligence-powered tool aimed at helping members find care within its network. Provider Connect uses a proprietary matching engine to recommend the best provider for each user, including quality score descriptions. The integrated platform built into its AI assistant is built on “tens of billions” of clinical and cost point data from millions of patients and uses more than 300 specialty-specific quality measures, the company said. “With this release, we’re making it much easier to leverage the power of AI to highlight some of these features and make…
Bedfont® Scientific Limited, an innovative MedTech company specializing in the design and manufacture of medical breath analyzers, is thrilled to have been shortlisted in the Export Performance category of the Science and Engineering Health Technologies Alliance (SEHTA) Healthcare Business Awards 2026. The SEHTA Healthcare Business Awards are one of the Southeast’s leading healthcare innovation awards, celebrating excellence in healthcare, particularly life sciences and medical technology. Bedfont® is a world leader in breath analysis and has experienced significant growth over the past decade, with a strong focus on international sales, with over 59% of export sales contributing to annual sales. Being…
Health tech founders, engineers, and IT pros: Telemedicine, wearables, and AI diagnostics are key to overcoming access gaps, burnout, and delayed care. Explore 2026 trends driving scalable digital health innovations.
An early warning system for sepsis, one of the deadliest infections for hospitalized patients, has been approved for use by the FDA, making it one of the first AI-based medical tools to receive clearance. The tool, developed by researchers at Johns Hopkins University and now commercialized by Bayesian Health, detects sepsis hours earlier than doctors and reduces deaths by almost 20%. “Pre-suspect screening is what creates lead time, and lead time is what changes sepsis outcomes. Once a clinician already suspects sepsis, the clock continues to tick, often for hours and even days,” says lead researcher Suchi Sarria. He is…
Enterprise Therapeutics Ltd. (Enterprise), a biopharmaceutical company dedicated to discovering and developing new treatments to improve the lives of people with respiratory diseases, today announced that a Phase 2 study of ETD001, the company’s lead candidate for the treatment of cystic fibrosis (CF), achieved key efficacy results. This study aimed to investigate the efficacy, safety, tolerability, and pharmacokinetics of inhaled ETD001 in the 10% of patients with CF (pwCF) who do not benefit from treatment with CFTR modulators and have the highest unmet medical need. Data from this trial showed improved lung function over 28 days compared to placebo. ETD001…
Recent research published in Journal of Experimental Politics This suggests that threatening men’s sense of masculinity may not lead them to adopt more conservative or typically masculine political beliefs. Researchers tested thousands of participants across the United States and found no consistent evidence that making men feel insecure about their gender identity changes their political attitudes. In both popular culture and politics, many commentators argue that society is facing a crisis of masculinity. Some politicians have made this idea central to their campaign platforms, suggesting that traditional masculinity is under attack. Sociologists and psychologists often attribute the rise in far-right…
Bicara Therapeutics prepares to accelerate cancer drug approvals next year, with the biotechnology company appointing Chris Sarchi as chief commercial officer. Mr. Sarchi joins Bicara after three and a half years at cancer drug maker Replimune. Just last month, the company laid off hundreds of employees after the FDA rejected its melanoma drug. Prior to that, he spent five years at French pharmaceutical giant Sanofi in oncology and transplant roles in the United States, and five years at German pharmaceutical company Boehringer Ingelheim. Mr. Sarchi joins Vicara at a pivotal time in Vicara’s history. In 2024, the company raised $362…